Jagsonpal Pharmaceuticals Limited

About Jagsonpal Pharmaceuticals Limited

No company profile on record yet.

Key facts

BSE symbol507789

NSE symbolJAGSNPHARM

ISININE048B01035

CINL74899DL1978PLC009181

Listing date1 Mar 2000

Fiscal year end31 Mar

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

AuditorAyush Khandelwal & Associates (Ayush Khandelwal)

Registered officeInnov8, 3rd Floor, Plot No. 211, Okhla Phase 3, New Delhi-110020

Registrar & transfer agentMCS SHARE TRANSFER AGENT LTD. 179-180, 3rd Floor, DSIDC Shed, Okhla Industrial Area, Phase-I, New Delhi - 110020.

Financial performance

Full financials →

Fiscal year	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Total income (before exceptional items)	299^†	277^†	218^†	242^†	229^†
Net profit	43	55	22	27	20^†

₹ Crore. ^† Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

Name	Designation	Term end
Manish Gupta	Executive Director	June 30, 2026
Anil Kumar Matai	Independent Director	June 30, 2026
Debasis Bikash Nandy	Independent Director	June 30, 2026
Radhika Madhukar Dudhat	Independent Director	June 30, 2026
Harsha Raghavan	Non-Executive Director	June 30, 2026
Prithipal Singh Kochhar	Non-Executive Director	June 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.